Krzysztof Potempa Profile picture
Founder & CEO @BRAINCURESLtd and dreamster dedicated to prevention and treatment of mental health disorders that affect at least 1 in 6 people worldwide
Aug 18, 2023 100 tweets 36 min read
🧵 A neonatal nurse has been found guilty of murdering seven babies and attempting to kill 6 more, making her the worst child serial killer in modern British history and raising urgent questions over whether her crimes could have been stopped
@joshhalliday
theguardian.com/uk-news/2023/a… Lucy Letby guilty of murdering seven babies as Angel of Death nurse at NHS hospital. She was working as a nurse at the neonatal unit at the Countess of Chester Hospital, where she was accused of murdering seven babies and trying to kill 10 others
mirror.co.uk/news/uk-news/b…
Mar 14, 2023 9 tweets 5 min read
Can you imagine applying biological intelligence-BI to achieve a 3 to 5-fold increase on AstraZeneca’s reported 19% success rate in the proportion of pipeline molecules that advance from preclinical investigation to completion of Phase III clinical trials?
bioindustry.org/news-listing/m… @BraincuresLTD's biological intelligence (BI) approach eliminated 59 of 72 target-compound pairs associated with Phase III clinical failures to enable 60 to 100% likelihood of clinical success rates across compounds that target 13 different protein classes
bioindustry.org/news-listing/m…
Mar 13, 2023 16 tweets 17 min read
🧵@KQLabs is a major initiative, delivered by @TheCrick supported by funding from @InnovateUK, and with collaboration from the @KQ_London @HDR_UK @GenomicsEngland, which aims to bring together a powerful eco-system in support of data-driven health startups
knowledgequarter.london/kq-labs/ Providing critical support to early stage data-driven health science startups, @KqLabs offers a customised framework with a 16-week accelerator programme. The program also includes workshops to inspire and nurture the next generation of start-ups
@TheCrick
crick.ac.uk/news/2018-09-1…
Mar 13, 2023 7 tweets 7 min read
🧵 @miramurati is a name that is gaining recognition in the world of artificial intelligence (AI). She is the brain behind the development of @OpenAI's ChatGPT, an #AI language model that has revolutionized the way we interact with machines @GlobalWomanCo
globalwomanmagazine.com/mira-murati-th… ChatGPT is essentially a large conversational model—a big neural net that’s been trained to predict the next word—and the challenges with it are similar challenges we see with the base large language models: it may make up facts
@MiraMurati CTO @OpenAI #AI
time.com/6252404/mira-m…
Mar 11, 2023 12 tweets 8 min read
Greg Becker, the CEO of Silicon Valley Bank sold $3.57 million of stock at an average price of $287.42 in a sell-off two weeks before it collapsed. CFO Daniel Beck ditched $575,000. The price plunged to just $39.49 before the FDIC seized the bank's assets
dailymail.co.uk/news/article-1… Federal Deposit Insurance Corporation @FDICgov, which typically protects deposits up to $250,000, said it had taken charge of the roughly $175bn (£145bn) in deposits held at the Silicon Valley Bank, the 16th largest in the US @shermannatalie @JamesClayton5
bbc.co.uk/news/business-…
Mar 11, 2023 6 tweets 14 min read
Women in Innovation Programme was launched in 2016 by @innovateuk with the overall aim of increasing gender equality in business-led innovation. The annual competition supports and celebrates remarkable #women entrepreneurs & senior business leaders @KTNUK
iuk.ktn-uk.org/programme/wome… #WomenInInnovation
Katerina Spranger-@OxfordHeartbeat
Claire Trant-Untap
@lornuccia-Phyona
Monika Tomecka-@uFraction8
@LydiaMapstone-@BoobyBiome
Louise Ben-Nathan-@LBNInnovations
Divia Bhatnagar-Medical Intelligence Group
@JoBarrow-Curb Health
@KTNUK #SDG5
iuk.ktn-uk.org/programme/wome…
Dec 17, 2022 4 tweets 3 min read
@KaterinaGalai, spoke to @SamBarrell1 about her career as an accomplished healthcare leader, including her leadership role at Europe’s largest single-site biomedical research organisation, the Francis Crick Institute @TheCrick, during the COVID-19 pandemic
cogconsortium.uk/women-in-cog-i… Sam “only ever planned one thing…and that was to be a doctor. For me, it’s just about being open-minded, enjoying challenges and being able to overcome them.” @SamBarrell1 prioritises one factor when considering a position: “they have to be purpose-led.”
Dec 16, 2022 14 tweets 7 min read
885 of all small molecule drugs pass the rule-of-five test; of these, 619 (70%) are actually dosed orally, whereas 159 (20%) of orally dosed drugs fail at least one of the rule-of-five parameters
-John P Overington, Bissan Al-Lazikani and Andrew L Hopkins
nature.com/articles/nrd21… @johnpoverington et al determine that all current drugs with a known mode-of-action act through 324 distinct molecular drug targets. 266 are human-genome-derived proteins, and the remainder are bacterial, viral, fungal or other pathogenic organism targets
readcube.com/articles/10.10…
Dec 13, 2022 12 tweets 7 min read
Psychologist Dr. Lee-Anne Gray founded a school whose mission is “Empathic Education for a Compassionate Nation.” She teaches the art of empathic listening and it is a powerful technique to dismantle normalized bullying in our society @bulliedbrain #resist
psychologytoday.com/ca/blog/the-bu… Identifying with the aggressor is comparable to Stockholm syndrome, in which a hostage will bond with their captor. This bonding occurs because the brain is aware that the captor could harm or kill the #hostage. The bond intensifies as a survival strategy
psychologytoday.com/ca/blog/the-bu…
Dec 12, 2022 13 tweets 8 min read
In 2018, @pfizer had turned to Kathrin and her research team to identify a partnership that would advance mRNA development for a game-changing seasonal flu vaccine. During the #partnership search, she made fast friends with the Turkish-German cofounder and BioNTech CEO Ugur Sahin Pfizer signed a collaboration agreement to codevelop a first-in-class, mRNA-based coronavirus vaccine, aimed at preventing COVID-19 infection. BioNTech received $72 million up-front & was eligible for future milestone payments of an additional $563 million
amazon.com/Moonshot-Pfize…
Dec 11, 2022 8 tweets 6 min read
The myopic focus of companies on profits has been criticized in recent years. Mads Øvlisen, the former CEO of @NovoNordisk, explains how the pursuit of a corporate purpose beyond short-term profits, can actually lead to higher long-term profits @TimaBansal
forbes.com/sites/timabans… Corporate purpose isn’t just about vision and values, it’s about keeping an eye on the long term. Upholding #corporate purpose requires leaders to resist the short-term demands of shareholders & investors in order to build good & successful companies #CSR
forbes.com/sites/timabans…
Dec 5, 2022 6 tweets 4 min read
🧵 What kind of vaccine are you hoping for?

@JeremyFarrar: (laughs) If I knew, I'd be a @NobelPrize candidate–or a multibillionaire...
It would be a once-in-a-lifetime vaccine like the one against measles,
it would cost a cent,
it would block transmission
spiegel.de/international/… Is it still possible to find a vaccine for this soup of different variants?
@JeremyFarrar: We have to get ourselves out of that situation. And I think the only way we're going to get ourselves out of that is the generation of vaccines
@bredow @VHackenbroch
Dec 4, 2022 7 tweets 4 min read
We have tested the antibody in various doses on 856 patients on 3 continents. After only 6 months we observed positive results, and after 18 months 81% of the group receiving the highest dosage showed lower levels of amyloid beta than the level we measure in Alzheimer’s-Lannfelt “The idea for the antibody originated back in the 1990s, when the team identified a change in the genetic material of a Swedish family that had been severely afflicted by Alzheimer's disease. The mutation indicated that the cause seemed to be protofibrils”
medicalxpress.com/news/2018-10-a…
Dec 4, 2022 8 tweets 7 min read
“I hope that Dr. Tessier-Lavigne will not brush off these concerns as irrelevant. There appear to be a lot of visible errors in these papers, and some duplications are suggestive [of] an intention to mislead,” @MicrobiomDigest
@deemostofi @StanfordDaily
stanforddaily.com/2022/11/29/sta… The @StanfordDaily reached out to Science and @Nature, where another of Tessier-Lavigne’s papers containing alleged data alteration was published, for comment. @ScienceMagazine's editor-in-chief @hholdenthorp wrote in an email that he would “check around.”
Dec 4, 2022 4 tweets 4 min read
Right now, we're going after the pathology of the disease–plaques & tangles-but I think we need to start going after the biology and, as a result, the pharmacology that addresses the altered biology with aging that occurs in Alzheimer's-@a_hfillit @TheADDF
biospace.com/article/ctad-2… “Lecanemab slows #cognitivedecline. But this is only a start to stopping Alzheimer’s in its tracks. We have a lot of ground to cover to get from the 27% slowing #lecanemab offers to our goal of slowing cognitive decline by 100%"-@a_hfillit on #CTAD22 data
alzdiscovery.org/news-room/anno…
Dec 3, 2022 5 tweets 5 min read
Today, almost half of the 4 million Americans living with type 1 diabetes use devices called continuous glucose monitors, or CGMs, to monitor their #glucose levels and regulate their insulin levels in real-time.
@statnews' @KatieMPalmer reviews CGM's here:
reports.statnews.com/products/conti… @statnews unpacks the differences between the different ways the FDA approves drugs, like accelerated approvals, fast-track designations, and emergency use authorizations. It touches on how we got here, where the agency is headed next, and what's at stake
reports.statnews.com/products/speed…
Dec 3, 2022 7 tweets 4 min read
🧵Since the first β-lactam, aminoglycoside, macrolide, tetracycline, and fluoroquinolone classes of antibiotics were discovered and approved from 1940 to 1980, few #antibiotics with novel mechanisms of action have been developed
@thomasmd @akesselheim #AMR
science.org/doi/10.1126/sc… Phase III clinical trials of a antibiotic in a single disease indication cost about US$70 million. Funding for biotech companies—venture capital or government grants—cannot cover this for a drug that will be sold mainly in short courses
Cooper M & Shlaes D
nature.com/articles/47203…
Dec 3, 2022 5 tweets 4 min read
After 18 months, participants who received lecanemab scored, on average, 0.45 points better on the CDR-SB than those who got a placebo. Some researchers, however, have questioned whether this shift is big enough to make a noticeable difference in a person’s symptoms @meprillaman It’s a modest benefit, says @BrentForester, director of the Geriatric Psychiatry Research Program @McLeanHospital who helped to run the clinical trial for lecanemab. His concerns lie with safety. About 20% of treated people had brain-scan anomalies
#CTAD22
Dec 2, 2022 7 tweets 5 min read
ANAVEX®2-73-AD-004 was a randomized, double-blind, multicenter, placebo-controlled 509 patient Phase 2b/3 study (randomized 1:1:1 to mid or high dose of ANAVEX®2-73 or placebo), for the treatment of early Alzheimer’s disease over 48 weeks @AnavexLifeSci
anavex.com/post/anavex-2-… We are very pleased to see such positive clinical data in patients with Alzheimer’s, thereby emphasizing the potentially significant implications these findings have for patients, caregivers & healthcare systems worldwide
-Edward Hammond CMO @AnavexLifeSci
finance.yahoo.com/news/anavex-2-…
Nov 22, 2022 7 tweets 5 min read
Credibility in Neuroscience
Introducing @BritishNeuro & credibility in science
How statistical power influences expected reproducibility-Johan Carlin @johancarlin
Registered reports-Guillaume Rousselet @robustgar
Preregistration posters-Rik Henson @rikhens
Two cognitive biases that make it hard to do science well
-Confirmation bias: selective attention/memory
-Failure to understand probability
Nov 21, 2022 4 tweets 4 min read
#OfficeForTheWhistleblower
"It is important that people have a reliable route that they can take when they want to expose wrongdoing. An office for the whistleblower might be a potential route."
-@MaryRobinson01 Chair @AWhistleblowing
lordslibrary.parliament.uk/office-of-the-…
#Whistleblower #SDG16 Legislation is needed to clarify that whistleblowing should be viewed positively, like compliance, rather than negatively, like a form of corporate treachery that eventually unravels in costly, exhausting & embarrassing legal battles
-Georgina Halford-Hall